Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist
We report the discovery of piperazine urea based compound 1, a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist. Compound 1 shows anti-obesity efficacy without potentiating erectile activity in the rodent models. We report the discovery of piperazine urea based...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2011-04, Vol.21 (8), p.2330-2334 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | We report the discovery of piperazine urea based compound
1, a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist. Compound
1 shows anti-obesity efficacy without potentiating erectile activity in the rodent models.
We report the discovery of piperazine urea based compound
1, a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist. Compound
1 shows anti-obesity efficacy without potentiating erectile activity in the rodent models. |
---|---|
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2011.02.090 |